ULBP1 antibody
Quick Overview for ULBP1 antibody (ABIN7120610)
Target
See all ULBP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- ULBP1 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- UL16 binding protein 1
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:200-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- ULBP1 (UL16 Binding Protein 1 (ULBP1))
-
Alternative Name
- ULBP1
-
Background
-
Synonyms: UL16-binding protein 1|ALCAN-beta|NKG2D ligand 1 (N2DL-1, NKG2DL1)|Retinoic acid early transcript 1I|ULBP1|N2DL1|RAET1I
Background: Ligand for the KLRK1/NKG2D receptor, together with at least ULBP2 and ULBP3. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to KLRK1/NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. In CMV infected cells, interacts with soluble CMV glycoprotein UL16. The interaction with UL16 blocked the interaction with the KLRK1/NKG2D receptor, providing a mechanism by which CMV infected cells might escape the immune system. UL16 also causes ULBP1 to be retained in the ER and cis-Golgi apparatus so that it does not reach the cell surface.
-
Molecular Weight
- 30 kDa, 37 kDa
-
Gene ID
- 80329
-
UniProt
- Q9BZM6
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-